CLBS14 (low-dose)
24779
Phase 2 mab completed
Quick answer
CLBS14 (low-dose) for Myocardial Ischemia is a Phase 2 program (mab) at LISATA THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- LISATA THERAPEUTICS, INC.
- Indication
- Myocardial Ischemia
- Phase
- Phase 2
- Modality
- mab
- Status
- completed